Medical Devices Seed Investors & VC Firms

1155 firms in this list, with a median first check of $500K. 233 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
MO Mountain State Capital MGDNMHNP4 people	88🔒	Morgantown	US	Seed–Series A	$200K – $500K	+ Add to CRM
TH Thursday Ventures Management Llc JFMSRMCK4 people · Leads rounds	88🔒	Brandon	US	Seed–Growth	—	+ Add to CRM
CR Crossroads Health Ventures TGVWSGCL6 people	88🔒	Indianapolis	US	Pre-Seed–Series A	—	+ Add to CRM
JU Julian Capital JSJJJFJ4 people · Leads rounds	88🔒	Austin	US	Pre-Seed–Seed	$400K – $2M	+ Add to CRM
NO Novalis LifeSciences MDDLPMCG9 people	88🔒	Portsmouth	US	Seed–Late Stage	—	+ Add to CRM
PB PBM Capital PBJRJPSG6 people	88🔒	Charlottesville	US	Seed–Late Stage	—	+ Add to CRM
PE Percipient Capital EFJGJB3 people	88🔒	London	GB	Seed–Late Stage	$1.3M – $6.3M	+ Add to CRM
SB SBCVC CSKCMZAS6 people	88🔒	Tortola	CN	Seed–Late Stage	—	+ Add to CRM
TE Tern ASBLIRIR6 people	88🔒	London	GB	Seed	—	+ Add to CRM
WA Waterman Ventures PRMKWV3 people	88🔒	Utrecht	NL	Seed–Late Stage	—	+ Add to CRM
CA Catalpa Ventures CGNWSRTG5 people · Leads rounds	88🔒	Grevenmacher	LU	Pre-Seed–Series A	$330K – $1.6M	+ Add to CRM
HB HBM Partners DDDUFDFD5 people	88🔒	Zug	CH	Pre-Seed–Late Stage	$5M – $50M	+ Add to CRM
JJ JJDC FMHPLTTM11 people	88🔒	New Brunswick	US	Seed–Series B	$500K – $5M	+ Add to CRM
NE NewMargin Ventures YHCTHHHK5 people	88🔒	Shanghai	CN	Pre-Seed–Late Stage	$425K – $200M	+ Add to CRM
VE Venture TKAHAKAF8 people	88🔒	Zurich	CH	Pre-Seed–Series B	—	+ Add to CRM
VE Vespucci Partners LZJSPMJS5 people	88🔒	Budapest	HU	Seed–Series A	$648K – $4.9M	+ Add to CRM
TR TRICAPITAL LCSA2 people · Leads rounds	88🔒	Scottish Borders	GB	Seed–Growth	$315K – $2.5M	+ Add to CRM
SP Split Rock Partners DSJSMGSZ4 people · Leads rounds	88🔒	Eden Prairie	US	Seed–Late Stage	$2M – $40M	+ Add to CRM
TA Target Partners BVKMKMWJ10 people	88🔒	Munich	DE	Seed–Late Stage	$1.1M – $3.2M	+ Add to CRM
ES Eshelman Ventures, LLC FEAMNH3 people	88🔒	Wilmington	US	Seed–Series A	—	+ Add to CRM
4S 4see Ventures RBDB2 people	88🔒	Chêne-Bougeries	CH	Pre-Seed–Series B	$432K – $1.1M	+ Add to CRM
CA Castel Capital ACJHMLPV4 people · Follows rounds	88🔒	Paphos	CY	Seed–Growth	$100K – $1M	+ Add to CRM
DE Dementia Discovery CJLBDLGF6 people · Follows rounds	88🔒	London	GB	Pre-Seed–Series C	—	+ Add to CRM
HT HTGF RSAVDA3 people · Follows rounds	88🔒	Bonn	DE	Pre-Seed–Series A	$1.1M	+ Add to CRM

Mountain State Capital

MorgantownSeed–Series A$200K – $500K

MGDNMHNP4 people

Thursday Ventures Management Llc

BrandonSeed–Growth

JFMSRMCK4 people

Crossroads Health Ventures

IndianapolisPre-Seed–Series A

TGVWSGCL6 people

Julian Capital

AustinPre-Seed–Seed$400K – $2M

JSJJJFJ4 people

Novalis LifeSciences

PortsmouthSeed–Late Stage

MDDLPMCG9 people

PBM Capital

CharlottesvilleSeed–Late Stage

PBJRJPSG6 people

Percipient Capital

LondonSeed–Late Stage$1.3M – $6.3M

EFJGJB3 people

SBCVC

TortolaSeed–Late Stage

CSKCMZAS6 people

Tern

LondonSeed

ASBLIRIR6 people

Waterman Ventures

UtrechtSeed–Late Stage

PRMKWV3 people

Catalpa Ventures

GrevenmacherPre-Seed–Series A$330K – $1.6M

CGNWSRTG5 people

HBM Partners

ZugPre-Seed–Late Stage$5M – $50M

DDDUFDFD5 people

JJDC

New BrunswickSeed–Series B$500K – $5M

FMHPLTTM11 people

NewMargin Ventures

ShanghaiPre-Seed–Late Stage$425K – $200M

YHCTHHHK5 people

Venture

ZurichPre-Seed–Series B

TKAHAKAF8 people

Vespucci Partners

BudapestSeed–Series A$648K – $4.9M

LZJSPMJS5 people

TRICAPITAL

Scottish BordersSeed–Growth$315K – $2.5M

LCSA2 people

Split Rock Partners

Eden PrairieSeed–Late Stage$2M – $40M

DSJSMGSZ4 people

Target Partners

MunichSeed–Late Stage$1.1M – $3.2M

BVKMKMWJ10 people

Eshelman Ventures, LLC

WilmingtonSeed–Series A

FEAMNH3 people

4see Ventures

Chêne-BougeriesPre-Seed–Series B$432K – $1.1M

RBDB2 people

Castel Capital

PaphosSeed–Growth$100K – $1M

ACJHMLPV4 people

Dementia Discovery

LondonPre-Seed–Series C

CJLBDLGF6 people

HTGF

BonnPre-Seed–Series A$1.1M

RSAVDA3 people

Data sourced from public filings and firms' own websites — see our methodology.